Esketamine added to nerve block for recent shingles pain
Treatments studied
Part of Infections clinical trials.
This study tests whether adding a medicine called esketamine to a standard nerve block procedure can improve pain relief for people with shingles-related nerve pain. If you have had shingles pain for less than 3 months, this might help reduce pain and prevent long-term discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your shingles rash started within the last 3 months (90 days).
- The rash is on your back, chest, or neck area (spinal nerves).
- Your pain is at least a 4 on a 0-10 scale (0 = no pain, 10 = worst pain).
- You are scheduled to have a CT-guided nerve block (PRF) for pain, or are discussing it with your doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug venlafaxine, usually used for depression, can help prevent long-term nerve pain (postherpetic neuralgia) after a shingles infection. If you are currently experiencing shingles pain, joining this study might reduce your chances of developing chronic pain later.
This study tests if electroacupuncture can help calm the immune system and reduce shingles pain. It is for women aged 50–70 who have had a shingles rash for 7 days or less and have not yet taken any medication for their shingles.
This trial compares two procedures—a nerve block injection and a radiofrequency treatment—to see which works better for lasting pain after shingles. It aims to help people with persistent pain in the neck, chest, or lower back.
This study tests a combination of two treatments for long-term nerve pain after shingles: a medication called esketamine and a nerve block (pulsed radiofrequency) applied to the affected spinal nerves. The goal is to see if this combination relieves the burning or shooting pain better than the nerve block alone.
This trial tests whether adding a medication called esketamine to a standard nerve procedure (pulse radiofrequency) can better reduce facial pain from shingles. Esketamine may help block pain signals more effectively.
This trial tests whether adding esketamine (a medicine related to ketamine) to a standard nerve treatment (pulsed radiofrequency) can better relieve face pain caused by shingles. It may help if you have ongoing, moderate-to-severe pain in your face or scalp.
Hear when a new Herpes Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.